Inactive Instrument

Company Cambrex Corporation

Equities

CBM

Pharmaceuticals

Business Summary

Cambrex Corporation (Cambrex) is a United States-based small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle. The company provides customers with an end-to-end partnership for the research, development and manufacture of small molecule therapeutics. The Company offers a range of specialist drug substance technologies and capabilities including biocatalysis, continuous flow, controlled substances, solid state science, material characterization and potent application program interface. In addition, it also supports conventional dosage forms including oral solids, semi-solids and liquids and has the capabilities to manufacture specialist dosage forms such as modified-release, fixed dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile and non-sterile ointments.

Managers

Managers TitleAgeSince
Chief Executive Officer 61 20-09-06
Director of Finance/CFO 65 -
Chief Operating Officer - -
Director/Board Member 47 09-03-31
Corporate Officer/Principal - -
Human Resources Officer 63 19-06-24
Comptroller/Controller/Auditor 57 04-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 47 09-03-31
65 -
Chairman 59 19-11-30
61 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 34,988,476 33,569,952 ( 95.95 %) 1,264,109 ( 3.613 %) 95.95 %

Company contact information

Cambrex Corp.

1 Meadowlands Plaza

07073, East Rutherford

+201-804-3000

http://www.cambrex.com
address Cambrex Corporation(CBM)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Cambrex AB
Financial Conglomerates
Miscellaneous
Chemicals: Specialty
Pharmaceuticals: Major
Pharmaceuticals: Major
  1. Stock Market
  2. Equities
  3. CBM Stock
  4. Company Cambrex Corporation